Morrison S A, Jesty J
Blood. 1984 Jun;63(6):1338-47.
Recent investigations have suggested that the activation of factor IX by factor VII/tissue factor may be an important alternative route to the generation of factor Xa. Accordingly, we have compared the tissue factor-dependent activation of tritium-labeled factor IX and factor X in a human plasma system and have studied the role of proteases known to stimulate factor VII activity. Plasma was defibrinated by heating and depleted of its factors IX and X by passing it through antibody columns. Addition of human brain thromboplastin, Ca2+, and purified 3H-labeled factor X to the plasma resulted, after a short lag, in burst-like activation of the factor X, measured as the release of radiolabeled activation peptide. The progress of activation was slowed by both heparin and a specific inhibitor of factor Xa, suggesting a feedback role for this enzyme, but factor X activation could not be completely abolished by such inhibitors. In the case of 3H-factor IX activation, the rate also increased for approximately 3 min after addition of thromboplastin, but was not subsequently curtailed. A survey of proteases implicated as activators of factor VII in other settings showed that both factor Xa and (to a much smaller extent) factor IXa could accelerate the activation of factor IX. However, factor Xa was unique in obliterating activation when present at concentrations greater than approximately 1 nM. Heparin inhibited the tissue factor-dependent activation of factor IX almost completely, apparently through the effect of antithrombin on the feedback reactions of factors Xa and IXa on factor VII. These results suggest that a very tight, biphasic control of factor VII activity exists in human plasma, which is modulated mainly by factor Xa. Variation of the factor IX or factor X concentrations permitted kinetic parameters for each activation to be derived. At saturation of factor VIIa/tissue factor, factor IX activation was significantly more rapid than was previously found in bovine plasma under similar conditions. The activation of factor X at saturation was slightly more rapid than in bovine plasma, despite the presence of heparin.
最近的研究表明,因子VII/组织因子对因子IX的激活可能是生成因子Xa的一条重要替代途径。因此,我们在人血浆系统中比较了氚标记的因子IX和因子X的组织因子依赖性激活,并研究了已知能刺激因子VII活性的蛋白酶的作用。血浆经加热去纤维蛋白,并通过抗体柱去除其中的因子IX和因子X。向血浆中加入人脑组织凝血活酶、Ca2+和纯化的3H标记因子X后,经过短暂延迟,因子X出现爆发式激活,以放射性标记激活肽的释放来衡量。肝素和因子Xa的特异性抑制剂均减慢了激活进程,提示该酶具有反馈作用,但此类抑制剂不能完全消除因子X的激活。就3H-因子IX的激活而言,加入组织凝血活酶后速率也在约3分钟内增加,但随后并未减缓。对在其他情况下被认为是因子VII激活剂的蛋白酶进行的调查显示,因子Xa和(程度小得多的)因子IXa均可加速因子IX的激活。然而,当因子Xa浓度大于约1 nM时,它能独特地消除激活作用。肝素几乎完全抑制了因子IX的组织因子依赖性激活,显然是通过抗凝血酶对因子Xa和因子IXa对因子VII的反馈反应的影响。这些结果表明,人血浆中存在对因子VII活性非常严格的双相控制,主要由因子Xa调节。因子IX或因子X浓度的变化使得能够得出每次激活的动力学参数。在因子VIIa/组织因子饱和时,因子IX的激活比以前在类似条件下的牛血浆中发现的要快得多。尽管存在肝素,但在饱和时因子X的激活比牛血浆中略快。